illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Emergent BioSolutions
Company logo

Emergent BioSolutions | Sustainability Performance

https://www.emergentbiosolutions.com
Linkedin

Develops products and technologies for public health threats, including vaccines and therapeutics. Focuses on addressing critical health challenges through innovation and preparedness.

1998

United States

501 - 1,000 employees

Biotechnology

$500M - 1B in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#12449
Overall
#2813
in United States
#245
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Digital emissions
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Arcturus Therapeutics

United States, Hospital & Health Care, Biotechnology

Company logo
NeueHealth

United States, Hospital & Health Care, Hospital & Health Care

Company logo
Envista

United States, Hospital & Health Care, Medical Device

Market cap

367.0M $, 2026▼14.7% YoY

Revenue

742.0M $, 2025▼40.6% YoY

R&D intensity

7.14% 2025

Digital Emissions

CO2e per visit (g)

Industry benchmark

B/M 0.26 g
0.4 g
B
Environmental ScoreScore B
Green HostingNo
Download Digital Emissions AnalysisPowered by illuminem and Dedalo AI

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

367.0M $, 2026▼14.7% YoY

Revenue

742.0M $, FY2025▼40.6% YoY

EBITDA

142.0M $, FY2025▼9.1% YoY

Operating margin

19% Industry: -370▲136% YoY

Revenue & EBITDA

$742.0MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Revenue by region

Revenue by region %

Canada
Other
United States

Powered by illuminem

Margin trends

Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

35.8M 2024▲838% YoY

Capex

22.0M 2024▼159.1% YoY

Debt/equity ratio

1.1 Industry: 2▼NaN% YoY

R&D intensity

7.1%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

5.0%FY2026
Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals

Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

1.0

▼ 1.7%

2023

1.0

▼ 7.0%

2024

0.7

▼ 8.3%

2025

1.0

2029

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

56%
Independent Directors

9 out of 16 incl. management

Powered by illuminem

Overall score

52

Environment

36

Social

65

Governance

54

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available

Sustainability employees

Total sustainability employees

4-6

    Available in
    Scale package

    Access
  • Email
  • Email